DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Neal B, Perkovic V, Mahaffey KW. et al.
Canagliflozin and cardiovascular and renal events in type 2 diabetes.
N Engl J Med 2017;
377: 644-657
We do not assume any responsibility for the contents of the web pages of other providers.